Potent tenofovir-containing antiretroviral regimens are increasingly used to treat and prevent HIV. Few data exist on the frequency of and risk factors for acquired drug resistance in regions hardest hit by the HIV pandemic. This collaborative study combined data from adult treatment cohorts and clinical...
It is our pleasure to announce the 10th International Workshop on HIV Treatment, Pathogenesis, and Prevention Research in Resource Limited Settings (INTEREST), on 3-6 May 2016 in the Hilton Yaoundé Hotel in Yaoundé, Cameroon. An exciting scientific program is being set up by the Organizing and...
On January 26th KIT will host a panel debate on the theme ‘From Innovation to Impact’. The event is a unique collaboration between KIT, KNCV Tuberculosis Foundation and the Bill & Melinda Gates Foundation. An introductory lecture by the renowned doctor & statistician Dr Hans...
Haroon Ali - "Alsof je een vitaminepil bij de maaltijd neemt" (deel 2, 16 januari 2016) Alles went, zelfs een dagelijkse dosis hiv-remmers. Alexander (49), Peter (42) en Giovanni (23) slikken sinds een half jaar iedere dag het preventieve hiv-medicijn PrEP, in de vorm van een...
Without antiretroviral treatment (ART), half of all children born with HIV will die before the age of two years. Although increasing numbers of children in resource-limited settings now have access to ART, important challenges remain. The World Health Organization recommends the use of protease inhibitors for...
Constance Schultsz et al. did a prospective study of acquisition of fecal colonisation and carriage with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in 2001 Dutch travellers (the COMBAT study),2from November, 2012, to November, 2013. Acquisition was defined as the absence of ESBL-producing Enterobacteriaceae in a fecal swab...